ZyVersa Therapeutics Inc (NASDAQ:ZVSA) has a beta value of 0.63 and has seen 63.32 million shares traded in the last trading session. The company, currently valued at $2.74M, closed the last trade at $2.54 per share which meant it gained $0.72 on the day or 39.56% during that session. The ZVSA stock price is -1568.5% off its 52-week high price of $42.38 and 28.35% above the 52-week low of $1.82. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.33 million shares traded. The 3-month trading volume is 146.91K shares.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA) trade information
Sporting 39.56% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the ZVSA stock price touched $2.54 or saw a rise of 24.63%. Year-to-date, ZyVersa Therapeutics Inc shares have moved -71.78%, while the 5-day performance has seen it change 24.51%. Over the past 30 days, the shares of ZyVersa Therapeutics Inc (NASDAQ:ZVSA) have changed 11.89%. Short interest in the company has seen 9687.0 shares shorted with days to cover at 0.18.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ZyVersa Therapeutics Inc (ZVSA) estimates and forecasts
Figures show that ZyVersa Therapeutics Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -60.74% over the past 6 months, with this year growth rate of 97.65%, compared to 17.30% for the industry.
ZVSA Dividends
ZyVersa Therapeutics Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA)’s Major holders
Insiders own 0.61% of the company shares, while shares held by institutions stand at 5.18% with a share float percentage of 5.21%. Investors are also buoyed by the number of investors in a company, with ZyVersa Therapeutics Inc having a total of 5.0 institutions that hold shares in the company.
